Blueprint Medicines Corpo...
106.35
3.79 (3.70%)
At close: Jan 15, 2025, 9:54 AM

Blueprint Medicines Corporation Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020
Collaboration and License Revenue 27.63M 24.04M 3.59M 125.26M 39.88M 39.07M 30.06M 8.96M 6.69M 6.31M 5.68M 3.46M
Collaboration and License Revenue Growth +14.94% +569.51% -97.13% +214.13% +2.07% +29.95% +235.72% +33.90% +6.02% +11.06% +64.26% n/a
Product Revenue 128.18M 114.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product Revenue Growth +12.33% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022
Non-Us Revenue 22.24M 13.77M
Non-Us Revenue Growth +61.52% n/a
United States Revenue 181.97M 97.23M
United States Revenue Growth +87.16% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 89.93M 89.34M 83.56M 79.27M 70.74M 71.93M 70.95M 64.02M 57.61M 58.69M 57.06M 54.20M 49.81M 49.29M 42.00M 42.54M 37.38M 42.17M 35.66M 32.27M 25.65M 21.92M 16.55M 13.64M 12.04M 12.33M 9.91M 8.09M 7.38M 6.83M 5.68M 4.99M 4.89M 4.69M 4.65M 3.62M 4.22M 3.84M 2.77M
Selling, General, and Administrative Revenue Growth +0.66% +6.92% +5.41% +12.06% -1.65% +1.38% +10.83% +11.13% -1.84% +2.86% +5.28% +8.82% +1.06% +17.34% -1.27% +13.82% -11.38% +18.28% +10.51% +25.80% +16.99% +32.44% +21.33% +13.30% -2.37% +24.44% +22.48% +9.68% +7.98% +20.24% +13.86% +2.00% +4.37% +0.90% +28.20% -14.16% +9.95% +38.63% n/a
Research and Development Revenue 85.30M 80.65M 83.38M 96.01M 110.25M 110.06M 112.07M 117.84M 127.98M 128.47M 103.13M 356.88M 84.42M 80.03M 79.71M 77.41M 74.23M 91.08M 84.15M 88.65M 81.45M 87.10M 74.25M 70.53M 64.56M 58.57M 49.95M 43.63M 39.30M 33.27M 28.49M 24.07M 18.15M 21.27M 17.64M 16.43M 11.68M 11.24M 9.23M
Research and Development Revenue Growth +5.76% -3.27% -13.15% -12.92% +0.17% -1.79% -4.89% -7.92% -0.38% +24.56% -71.10% +322.74% +5.49% +0.40% +2.98% +4.28% -18.50% +8.24% -5.08% +8.83% -6.48% +17.31% +5.27% +9.25% +10.22% +17.25% +14.50% +11.02% +18.12% +16.79% +18.34% +32.63% -14.68% +20.63% +7.32% +40.67% +3.90% +21.78% n/a
Sales and Marketing Revenue 26.74M 22.71M 16.93M 16.90M 13.07M 18.72M 10.05M 18.10M 7.72M n/a n/a 13.50M n/a n/a n/a 6.89M n/a n/a n/a 3.30M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth +17.76% +34.13% +0.18% +29.29% -30.17% +86.26% -44.48% +134.49% n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a